Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis.

Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B, Brewer WJ, Smith DJ, Dazzan P, Berger GE, Yung AR, van den Buuse M, Murray R, McGorry PD, Pantelis C.

Biol Psychiatry. 2005 Sep 1;58(5):417-23.

PMID:
16026767
2.

Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals.

Fornito A, Yung AR, Wood SJ, Phillips LJ, Nelson B, Cotton S, Velakoulis D, McGorry PD, Pantelis C, Yücel M.

Biol Psychiatry. 2008 Nov 1;64(9):758-65. doi: 10.1016/j.biopsych.2008.05.032. Epub 2008 Jul 17.

PMID:
18639238
3.

White-matter markers for psychosis in a prospective ultra-high-risk cohort.

Bloemen OJ, de Koning MB, Schmitz N, Nieman DH, Becker HE, de Haan L, Dingemans P, Linszen DH, van Amelsvoort TA.

Psychol Med. 2010 Aug;40(8):1297-304. doi: 10.1017/S0033291709991711. Epub 2009 Nov 9.

PMID:
19895720
4.

Caudate nucleus volume in individuals at ultra-high risk of psychosis: a cross-sectional magnetic resonance imaging study.

Hannan KL, Wood SJ, Yung AR, Velakoulis D, Phillips LJ, Soulsby B, Berger G, McGorry PD, Pantelis C.

Psychiatry Res. 2010 Jun 30;182(3):223-30. doi: 10.1016/j.pscychresns.2010.02.006. Epub 2010 May 20.

PMID:
20488675
5.

Pituitary volume in psychosis.

Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ, Brewer W, Smith DJ, Dazzan P, Yung AR, Zervas IM, Christodoulou GN, Murray R, McGorry PD, Pantelis C.

Br J Psychiatry. 2004 Jul;185:5-10.

6.

Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk.

Jang JH, Shin NY, Shim G, Park HY, Kim E, Jang GE, Kwon SJ, Hur JW, An SK, Kwon JS.

Aust N Z J Psychiatry. 2011 Sep;45(9):763-70. doi: 10.3109/00048674.2011.595684. Epub 2011 Aug 10.

PMID:
21827349
7.

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.

Arch Gen Psychiatry. 2006 Feb;63(2):139-49.

PMID:
16461856
8.

Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.

Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH.

Aust N Z J Psychiatry. 2010 Mar;44(3):230-6. doi: 10.3109/00048670903487118.

PMID:
20180725
9.

Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study.

Wood SJ, Kennedy D, Phillips LJ, Seal ML, Yücel M, Nelson B, Yung AR, Jackson G, McGorry PD, Velakoulis D, Pantelis C.

Neuroimage. 2010 Aug 1;52(1):62-8. doi: 10.1016/j.neuroimage.2010.04.012. Epub 2010 Apr 22.

PMID:
20399273
10.

Verbal fluency as a possible predictor for psychosis.

Becker HE, Nieman DH, Dingemans PM, van de Fliert JR, De Haan L, Linszen DH.

Eur Psychiatry. 2010 Mar;25(2):105-10. doi: 10.1016/j.eurpsy.2009.08.003. Epub 2009 Dec 14.

PMID:
20005685
11.

Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.

Takahashi T, Wood SJ, Yung AR, Phillips LJ, Soulsby B, McGorry PD, Tanino R, Zhou SY, Suzuki M, Velakoulis D, Pantelis C.

Schizophr Res. 2009 Jun;111(1-3):94-102. doi: 10.1016/j.schres.2009.03.024. Epub 2009 Apr 5.

PMID:
19349150
12.

Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.

Nieman DH, Rike WH, Becker HE, Dingemans PM, van Amelsvoort TA, de Haan L, van der Gaag M, Denys DA, Linszen DH.

Int Clin Psychopharmacol. 2009 Jul;24(4):223-8. doi: 10.1097/YIC.0b013e32832e0a76.

PMID:
19521246
13.

Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders.

Takahashi T, Yücel M, Yung AR, Wood SJ, Phillips LJ, Berger GE, Ang A, Soulsby B, McGorry PD, Suzuki M, Velakoulis D, Pantelis C.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1708-14. doi: 10.1016/j.pnpbp.2008.07.007. Epub 2008 Jul 15.

PMID:
18675876
14.

Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.

Lin A, Yung AR, Nelson B, Brewer WJ, Riley R, Simmons M, Pantelis C, Wood SJ.

Psychol Med. 2013 Nov;43(11):2349-60. doi: 10.1017/S0033291713000123. Epub 2013 Feb 6.

PMID:
23388122
15.

Cavum septum pellucidum in subjects at ultra-high risk for psychosis: compared with first-degree relatives of patients with schizophrenia and healthy volunteers.

Choi JS, Kang DH, Park JY, Jung WH, Choi CH, Chon MW, Jung MH, Lee JM, Kwon JS.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1326-30. doi: 10.1016/j.pnpbp.2008.04.011. Epub 2008 Apr 22.

PMID:
18513845
16.

Semantic fluency deficits and reduced grey matter before transition to psychosis: a voxelwise correlational analysis.

Meijer JH, Schmitz N, Nieman DH, Becker HE, van Amelsvoort TA, Dingemans PM, Linszen DH, de Haan L.

Psychiatry Res. 2011 Oct 31;194(1):1-6. doi: 10.1016/j.pscychresns.2011.01.004. Epub 2011 Aug 9.

PMID:
21831606
17.

Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: a systematic review and meta-analysis.

Nordholm D, Krogh J, Mondelli V, Dazzan P, Pariante C, Nordentoft M.

Psychoneuroendocrinology. 2013 Nov;38(11):2394-404. doi: 10.1016/j.psyneuen.2013.06.030. Epub 2013 Jul 25. Review.

PMID:
23890984
18.

Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.

Takahashi T, Wood SJ, Yung AR, Soulsby B, McGorry PD, Suzuki M, Kawasaki Y, Phillips LJ, Velakoulis D, Pantelis C.

Arch Gen Psychiatry. 2009 Apr;66(4):366-76. doi: 10.1001/archgenpsychiatry.2009.12.

PMID:
19349306
19.

Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.

Witthaus H, Kaufmann C, Bohner G, Ozgürdal S, Gudlowski Y, Gallinat J, Ruhrmann S, Brüne M, Heinz A, Klingebiel R, Juckel G.

Psychiatry Res. 2009 Sep 30;173(3):163-9. doi: 10.1016/j.pscychresns.2008.08.002. Epub 2009 Jul 17.

PMID:
19616415
20.

Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis.

Dazzan P, Soulsby B, Mechelli A, Wood SJ, Velakoulis D, Phillips LJ, Yung AR, Chitnis X, Lin A, Murray RM, McGorry PD, McGuire PK, Pantelis C.

Schizophr Bull. 2012 Sep;38(5):1083-91. doi: 10.1093/schbul/sbr035. Epub 2011 Apr 25.

Supplemental Content

Support Center